JP2004518657A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004518657A5 JP2004518657A5 JP2002551525A JP2002551525A JP2004518657A5 JP 2004518657 A5 JP2004518657 A5 JP 2004518657A5 JP 2002551525 A JP2002551525 A JP 2002551525A JP 2002551525 A JP2002551525 A JP 2002551525A JP 2004518657 A5 JP2004518657 A5 JP 2004518657A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydrogen
- alkyl
- alkoxy
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 18
- 239000001257 hydrogen Substances 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 13
- 125000005647 linker group Chemical group 0.000 claims 10
- 239000002253 acid Substances 0.000 claims 9
- 125000003545 alkoxy group Chemical group 0.000 claims 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims 7
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 6
- 125000002877 alkyl aryl group Chemical group 0.000 claims 5
- 150000002431 hydrogen Chemical class 0.000 claims 5
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 4
- 125000004442 acylamino group Chemical group 0.000 claims 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000003368 amide group Chemical group 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 239000011593 sulfur Substances 0.000 claims 4
- 125000006553 (C3-C8) cycloalkenyl group Chemical group 0.000 claims 3
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 3
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 3
- 125000003302 alkenyloxy group Chemical group 0.000 claims 3
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims 3
- 125000003282 alkyl amino group Chemical group 0.000 claims 3
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 3
- 125000005133 alkynyloxy group Chemical group 0.000 claims 3
- 239000004305 biphenyl Substances 0.000 claims 3
- 235000010290 biphenyl Nutrition 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000005425 toluyl group Chemical group 0.000 claims 3
- 125000002256 xylenyl group Chemical group C1(C(C=CC=C1)C)(C)* 0.000 claims 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- 125000000033 alkoxyamino group Chemical group 0.000 claims 2
- 125000004694 alkoxyaminocarbonyl group Chemical group 0.000 claims 2
- 150000001408 amides Chemical group 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000006649 (C2-C20) alkynyl group Chemical group 0.000 claims 1
- RLJUIKVXQJUBAN-UHFFFAOYSA-N 2-(1-benzyl-2-ethyl-3-oxamoylbenzo[f]indol-4-yl)oxyacetic acid Chemical compound CCC1=C(C(=O)C(N)=O)C2=C(OCC(O)=O)C3=CC=CC=C3C=C2N1CC1=CC=CC=C1 RLJUIKVXQJUBAN-UHFFFAOYSA-N 0.000 claims 1
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 claims 1
- 125000003358 C2-C20 alkenyl group Chemical group 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- -1 amino, carbonyl Chemical group 0.000 claims 1
- ZKYVBSXZRJFJRC-UHFFFAOYSA-N benzyl 2-(1-benzyl-2-ethyl-3-oxamoylbenzo[f]indol-4-yl)oxyacetate Chemical compound C12=CC=CC=C2C=C2N(CC=3C=CC=CC=3)C(CC)=C(C(=O)C(N)=O)C2=C1OCC(=O)OCC1=CC=CC=C1 ZKYVBSXZRJFJRC-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- GQBNRKIHKLCHTG-UHFFFAOYSA-N ethyl 2-(1-benzyl-2-ethyl-3-oxamoylbenzo[f]indol-4-yl)oxyacetate Chemical compound C12=CC3=CC=CC=C3C(OCC(=O)OCC)=C2C(C(=O)C(N)=O)=C(CC)N1CC1=CC=CC=C1 GQBNRKIHKLCHTG-UHFFFAOYSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 125000001188 haloalkyl group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25628100P | 2000-12-18 | 2000-12-18 | |
| PCT/US2001/043184 WO2002050028A2 (en) | 2000-12-18 | 2001-12-06 | Substituted benzoindoles as spla2 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004518657A JP2004518657A (ja) | 2004-06-24 |
| JP2004518657A5 true JP2004518657A5 (enExample) | 2005-12-22 |
Family
ID=22971644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002551525A Pending JP2004518657A (ja) | 2000-12-18 | 2001-12-06 | 新規なｓＰＬＡ２インヒビター |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6930123B2 (enExample) |
| EP (1) | EP1349832A2 (enExample) |
| JP (1) | JP2004518657A (enExample) |
| AU (1) | AU2002237655A1 (enExample) |
| CA (1) | CA2431023A1 (enExample) |
| WO (1) | WO2002050028A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101499882B (zh) | 2008-11-05 | 2011-05-04 | 华为技术有限公司 | 半静态调度数据包的应答信息的反馈、接收方法及其装置 |
| NZ720946A (en) | 2009-04-29 | 2017-09-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| KR101213495B1 (ko) * | 2010-06-03 | 2013-01-14 | 삼성디스플레이 주식회사 | 유기 발광 소자 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU163443B (enExample) * | 1970-08-26 | 1973-08-28 | ||
| AU6240099A (en) * | 1998-08-24 | 2000-03-14 | Susan E Draheim | Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase A2 |
| CA2356159A1 (en) * | 1998-12-22 | 2000-06-29 | Richard Waltz Harper | Novel spla2 inhibitors |
| CA2379208A1 (en) * | 1999-07-19 | 2001-01-25 | Eli Lilly & Company | Spla2 inhibitors |
| WO2001021587A2 (en) * | 1999-09-20 | 2001-03-29 | Eli Lilly And Company | Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
-
2001
- 2001-12-06 JP JP2002551525A patent/JP2004518657A/ja active Pending
- 2001-12-06 EP EP01986459A patent/EP1349832A2/en not_active Withdrawn
- 2001-12-06 US US10/450,929 patent/US6930123B2/en not_active Expired - Fee Related
- 2001-12-06 AU AU2002237655A patent/AU2002237655A1/en not_active Abandoned
- 2001-12-06 CA CA002431023A patent/CA2431023A1/en not_active Abandoned
- 2001-12-06 WO PCT/US2001/043184 patent/WO2002050028A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004518658A5 (enExample) | ||
| JP2014525425A5 (enExample) | ||
| RU2004117169A (ru) | Производные нафтиридина, их получение и их применение в качестве ингибиторов изофермента 4 фосфодиэстера (pde4) | |
| RU2006142738A (ru) | Антагонисты рецептора crth2 | |
| CA2401502A1 (en) | Carboxylic acid derivatives as ip antagonists | |
| JP2005519916A5 (enExample) | ||
| JP2014525426A5 (enExample) | ||
| CA2536136A1 (en) | Aryloxy and arylalkyleneoxy substituted imidazoquinolines | |
| JP2014525427A5 (enExample) | ||
| WO2008142482A3 (en) | Omega-3 lipid compounds | |
| JP2006509749A5 (enExample) | ||
| DK1642885T3 (da) | Anvendelse af et farmaceutisk præparat der indeholder et para-aminophenyl-eddikesyrederivat til behandling af inflammatoriske tilstande i mave-tarmkanalen | |
| JP2011500638A5 (enExample) | ||
| CA2436846A1 (en) | Thioether substituted imidazoquinolines | |
| JP2011063620A (ja) | ピペリジンおよびピペラジン誘導体 | |
| KR950701622A (ko) | 안기오텐신 ii 리셉터 안타고니스트 특성을 지니는 치환된 1,2,3,4-테트라하이드로 이소퀴놀린(substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ⅱ receptor antagonist properties) | |
| JP2007515405A5 (enExample) | ||
| EP2682387A3 (en) | C7-fluoro substituted tetracycline compounds | |
| HRP20070430T3 (en) | (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity | |
| JP2007516205A5 (enExample) | ||
| JP2004525183A5 (enExample) | ||
| HRP20100681T1 (hr) | Derivati hinaholina korisni za tretman periferne arterijske bolesti i kao inhibitori fosfodiesteraze | |
| JP2002522385A5 (enExample) | ||
| WO2009145816A3 (en) | Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents | |
| RU2004103079A (ru) | Новые иммуномодулирующие соединения |